Botswana continues to lead in the global fight against HIV/AIDS, taking a bold step forward with the finalization of its Integrated HIV Testing Services (HTS) Guidelines. This development was marked by a high-level workshop held in Gaborone, bringing together key stakeholders including the Ministry of Health, the World Health Organization (WHO), and development partners.

Speaking at the event, Director of Public Health Mr. Samuel Kolane reaffirmed Botswana’s position as a global frontrunner in HIV response. “With 95% of people living with HIV identified, 98% initiated on antiretroviral therapy, and 98% achieving viral suppression, we are on the right track,” he said. “But our ultimate goal remains zero new infections by 2030.” He emphasized that the updated guidelines are aimed at improving service delivery, expanding access to care, and promoting targeted testing, particularly for underserved communities.

A key highlight of the updated guidelines is the introduction of a three-test strategy for HIV diagnosis, a significant shift from the previous two-test approach. Dr. Busisiwe Radebe emphasized the critical need for quality and accuracy in HIV testing, warning that misdiagnosis can lead to serious consequences such as unnecessary treatment, psychological distress, and loss of trust in the healthcare system. “Unlike previous methods, the three-test strategy introduces an additional layer of verification, significantly reducing the risk of false-positive or false-negative results,” Dr. Radebe explained. “This is not just about improving accuracy, it’s about restoring and maintaining public confidence in our healthcare services.”

Dr. Tebogo Madidimalo, WHO Botswana’s focal person, underscored the strategic shift toward integrated testing. He said the guidelines now incorporate triple testing for HIV, syphilis, and hepatitis B, a more efficient and client-centered approach, especially for pregnant women under antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) programs.“These updated guidelines reflect WHO’s commitment to scientific rigor, innovation, and   access,” Dr. Madidimalo stated. “They are aligned with WHO-prequalified recommendations and tailored to meet Botswana’s unique needs.” He also commended the unwavering support of development partners, including the U.S. Government and the Global Fund, for their role in strengthening the country’s HIV response.

However, he cautioned that guidelines alone are not enough. “We need ongoing investment in capacity building, robust monitoring, and quality assurance systems to ensure lasting impact,” he said, reaffirming WHO’s continued commitment to supporting Botswana’s vision of an HIV-free future.

The workshop closed with a shared sense of optimism, as stakeholders agreed that with strong political will, international support, and scientifically sound strategies, Botswana is well-positioned to not only meet but surpass global targets, bringing the country closer to ending AIDS by 2030.